Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
7.66
+0.42 (5.80%)
At close: Dec 26, 2024, 4:00 PM
7.65
-0.01 (-0.13%)
After-hours: Dec 26, 2024, 7:59 PM EST

Recursion Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for RXRX stock have an average target of 9.25, with a low estimate of 6.00 and a high estimate of 12. The average target predicts an increase of 20.76% from the current stock price of 7.66.

Analyst Consensus: Buy
Target Low Average Median High
Price $6.00 $9.25 $11 $12
Change -21.67% +20.76% +43.60% +56.66%

Analyst Ratings

The average analyst rating for RXRX stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 211111
Buy 111111
Hold 324433
Sell 000000
Strong Sell 000000
Total 646655

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Needham
Needham
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +43.60% Dec 11, 2024
Needham
Needham
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +43.60% Nov 20, 2024
Needham
Needham
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +43.60% Nov 7, 2024
Needham
Needham
Strong Buy
Maintains
$16$11
Strong Buy Maintains $16$11 +43.60% Sep 4, 2024
Jefferies
Jefferies
Hold
Maintains
$8$6
Hold Maintains $8$6 -21.67% Sep 3, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
71.40M
from 44.58M
Increased by 60.17%
Revenue Next Year
85.59M
from 71.40M
Increased by 19.88%
EPS This Year
-1.62
from -1.58
EPS Next Year
-1.75
from -1.62
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
2.32M3.96M10.18M39.84M44.58M71.40M85.59M128.37M
Revenue Growth
-70.85%156.89%291.46%11.88%60.17%19.88%49.98%
EPS
-2.87-3.99-1.49-1.36-1.58-1.62-1.75-1.46
EPS Growth
--------
Forward PE
--------
No. Analysts -----11116
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 92.7M 183.8M 218.4M
Avg 71.4M 85.6M 128.4M
Low 44.1M 45.1M 73.6M

Revenue Growth

Revenue Growth 202420252026
High
108.0%
157.4%
155.2%
Avg
60.2%
19.9%
50.0%
Low
-1.1%
-36.9%
-14.0%

EPS Forecast

EPS 202420252026
High -1.52 -1.41 -1.12
Avg -1.62 -1.75 -1.46
Low -1.86 -2.84 -1.76

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.